Plasma cfDNA as a Potential Biomarker to Evaluate the Efficacy of Chemotherapy in Gastric Cancer

OBJECTIVE: To investigate the clinical value of plasma cell-free DNA (cfDNA) as a potential biomarker for advanced gastric cancer (GC). PATIENTS AND METHODS: One hundred and six cases of advanced gastric cancer patients receiving chemotherapy were selected as study objects. Another 40 healthy volunt...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Yuejiao, Fan, Qingyu, Zhou, Zhaofei, Wang, Yajing, He, Kang, Lu, Jianwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211302/
https://www.ncbi.nlm.nih.gov/pubmed/32440208
http://dx.doi.org/10.2147/CMAR.S243320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211302/
https://www.ncbi.nlm.nih.gov/pubmed/32440208
http://dx.doi.org/10.2147/CMAR.S243320

Ejemplares similares